Discover the latest news from the 11th European Breast Cancer Conference taking place in Barcelona, Spain (21–23rd March).
Browsing: Disease Area > Breast
Researchers have discovered 110 genes linked to an increased risk of breast cancer.
A novel study has demonstrated a blood test for circulating cancer DNA could predict if a woman is responding to the breast cancer drug palbociclib, months earlier than current tests.
A novel method has been developed to aid breast cancer diagnosis whilst reducing the number of unnecessary biopsies performed.
A novel viral-gene therapy could improve results from breast reconstruction surgery after cancer treatment by helping healthy tissue protect itself from radiotherapy damage.
An innovative new platform could transform the way cancer is diagnosed and treated by automating the isolation of circulating tumor cells.
From clinical trial results to major drug approvals, here we present an overview of the latest industry news from the biggest players in oncology.
Right now, doctors can’t tell whether women with DCIS will go on to develop breast cancer. This means that, unfortunately, some women with DCIS undergo unnecessary treatment. Find out how Jelle and his team are looking to change this.
The FDA has expanded the label for AstraZeneca’s oral PARP inhibitor olaparib to include the treatment of patients with metastatic breast cancer whose disease is associated with a BRCA gene mutation.